Delving into the Latest Updates on Sichuan Tiande Pharmaceutical Co. Ltd. with Synapse

Overview

Tags

Other Diseases

Skin and Musculoskeletal Diseases

Nervous System Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Nervous System Diseases	1
Immune System Diseases	1
Infectious Diseases	1
Endocrinology and Metabolic Disease	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

COXs(Cyclooxygenases)	1

主要目的：以四川天德制药有限公司生产的双氯芬酸钠肠溶片（规格：25 mg）为受试制剂，以北京诺华制药有限公司生产的双氯芬酸钠肠溶片（规格：25 mg，商品名：扶他林®）为参比制剂，进行餐后状态下人体生物等效性试验，评价受试制剂与参比制剂的生物等效性。次要目的：观察餐后状态下，受试制剂和参比制剂在健康研究参与者中的安全性。

[Translation]

Primary objective: To evaluate the bioequivalence of diclofenac sodium enteric-coated tablets (25 mg) manufactured by Sichuan Tiande Pharmaceutical Co., Ltd. in humans under postprandial conditions, using diclofenac sodium enteric-coated tablets (25 mg, trade name: Voltaren®) manufactured by Novartis Pharmaceuticals Co., Ltd. in Beijing as the reference formulation. Secondary objective: To observe the safety of the test and reference formulations in healthy study participants under postprandial conditions.

Start Date10 Dec 2025

Sponsor / Collaborator

Sichuan Tiande Pharmaceutical Co. Ltd.

CTR20240827

/ Not yet recruitingPhase 1

健康受试者空腹及餐后状态下口服双氯芬酸钠肠溶片后人体生物等效性试验

[Translation] Bioequivalence study of diclofenac sodium enteric-coated tablets in healthy subjects after fasting and postprandial administration

主要目的：以四川天德制药有限公司生产的双氯芬酸钠肠溶片（规格：25 mg）为受试制剂，以北京诺华制药有限公司生产的双氯芬酸钠肠溶片（规格：25 mg，商品名：扶他林®）为参比制剂，进行空腹/餐后状态下人体生物等效性试验，评价受试制剂与参比制剂的生物等效性。次要目的：观察空腹/餐后状态下，受试制剂和参比制剂在健康受试者中的安全性。

[Translation]

Main purpose: Diclofenac sodium enteric-coated tablets (specification: 25 mg) produced by Sichuan Tiande Pharmaceutical Co., Ltd. were used as the test preparation, and diclofenac sodium enteric-coated tablets (specification: 25 mg, trade name: Voltaren®) produced by Beijing Novatis Pharmaceutical Co., Ltd. were used as the reference preparation. Human bioequivalence studies were conducted under fasting/fed conditions to evaluate the bioequivalence of the test preparation and the reference preparation. Secondary purpose: To observe the safety of the test preparation and the reference preparation in healthy subjects under fasting/fed conditions.

Start Date-

Sponsor / Collaborator

Sichuan Tiande Pharmaceutical Co. Ltd.

CTR20222651

/ Not yet recruitingPhase 1

健康受试者空腹及餐后状态下口服双氯芬酸钠肠溶片后人体生物等效性试验

[Translation] Bioequivalence study of diclofenac sodium enteric-coated tablets in healthy subjects after fasting and postprandial administration

主要目的：以四川天德制药有限公司生产的双氯芬酸钠肠溶片（规格：25 mg）为受试制剂，以北京诺华制药有限公司生产的双氯芬酸钠肠溶片（规格：25 mg，商品名：扶他林®）为参比制剂，进行空腹/餐后状态下人体生物等效性试验，评价受试制剂与参比制剂的生物等效性。次要目的：观察空腹/餐后状态下，受试制剂和参比制剂在健康受试者中的安全性。

[Translation]

Main purpose: Diclofenac sodium enteric-coated tablets (specification: 25 mg) produced by Sichuan Tiande Pharmaceutical Co., Ltd. were used as the test preparation, and diclofenac sodium enteric-coated tablets (specification: 25 mg, trade name: Voltaren®) produced by Beijing Novatis Pharmaceutical Co., Ltd. were used as the reference preparation. Human bioequivalence studies were conducted under fasting/fed conditions to evaluate the bioequivalence of the test preparation and the reference preparation. Secondary purpose: To observe the safety of the test preparation and the reference preparation in healthy subjects under fasting/fed conditions.

Start Date-

Sponsor / Collaborator

Sichuan Tiande Pharmaceutical Co. Ltd.

100 Clinical Results associated with Sichuan Tiande Pharmaceutical Co. Ltd.

Login to view more data

0 Patents (Medical) associated with Sichuan Tiande Pharmaceutical Co. Ltd.

Login to view more data

100 Deals associated with Sichuan Tiande Pharmaceutical Co. Ltd.

Login to view more data

100 Translational Medicine associated with Sichuan Tiande Pharmaceutical Co. Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 18 Oct 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1

1

Login to view more data